The Kras + HPV + SONIC system successfully induced tumor growth in C57BL/6 mice under transient or selective immunosuppression, and these tumors were responsive to both therapeutic and preventative immunotherapeutic vaccination, demonstrating an HPV16 E7-specific immune response. Here, KRAS is linked to neoplasm.